Previous 10 | Next 10 |
CORAL GABLES, FL / ACCESSWIRE / March 11, 2019 / The success of the tech stock market is directly correlated to the operating assumption that tech companies are prepared to meet the rising challenges presently facing society. As consumers, we expect innovative companies in the tech industr...
Leap Therapeutics (NASDAQ: LPTX ) is up 3% postmarket after a disclosure from Valence Helix that it's acquired a 10.99% stake . More news on: Leap Therapeutics, Healthcare stocks news, Stocks on the move, Read more ...
MacroGenics (NASDAQ: MGNX ) +121% on positive margetuximab data . More news on: MacroGenics, Inc., Snap Inc., Zendesk, Inc., Stocks on the move, Read more ...
CAMBRIDGE, Mass. , Feb. 5, 2019 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced the closing of an underwritten public offering of 6,571,428 shares of its common stock a...
Gainers: TMSR Holding Company (NASDAQ: TMSR ) +223%. Integrated Media Technology (NASDAQ: IMTE ) +104% . Titan Pharmaceuticals (NASDAQ: TTNP ) +34%. Professional Diversity Network (NASDAQ: IPDN ) +30% . Continental Materials (NYSEMKT: CUO ) +29% . Gravity (NASDAQ: GRVY ) ...
Thinly traded nano cap Leap Therapeutics ( LPTX -23.6% ) slumps on more than a 9x surge in volume in reaction to its public offering of ~6.6M shares of common stock and warrants to purchase up to the same number shares at a combined price of $1.75. Gross proceeds should be ~$11.5M. Mor...
CAMBRIDGE, Mass. , Feb. 1, 2019 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced the pricing of an underwritten public offering of 6,571,428 shares of its common stock and ...
Vedanta (NYSE: VEDL ) -17% after Anglo American stake purchase . More news on: Vedanta Ltd, MagneGas Corporation, Leap Therapeutics, Stocks on the move, , Read more ...
Leap Therapeutics (NASDAQ: LPTX ) has tumbled 15.9% after hours following the announcement of an offering of common stock and warrants . More news on: Leap Therapeutics, Healthcare stocks news, Stocks on the move, Read more ...
CAMBRIDGE, Mass. , Jan. 31, 2019 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that it has commenced an underwritten public offering of its common stock and warrants...
News, Short Squeeze, Breakout and More Instantly...
Leap Therapeutics Inc. Company Name:
LPTX Stock Symbol:
NASDAQ Market:
Leap Therapeutics Inc. Website:
Leap Therapeutics Reports First Quarter 2024 Financial Results PR Newswire CAMBRIDGE, Mass. , May 13, 2024 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today report...
Leap Therapeutics Announces $40 Million Private Placement PR Newswire Net proceeds, along with existing cash, cash equivalents, and marketable securities are expected to extend cash runway into Q2 2026 and enable expansion of DKN-01 DeFianCe clinical trial and development prog...
Leap Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results PR Newswire CAMBRIDGE, Mass. , March 18, 2024 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeut...